Dynamics of histone H3.3 deposition in proliferating and senescent cells reveals a DAXX-dependent targeting to PML-NBs important for pericentromeric heterochromatin organization

References

• Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res 1961; 25:585 - 621; http://dx.doi.org/10.1016/0014-4827(61)90192-6; PMID: 13905658
   PubMed Web of Science ®Google Scholar
• Adams PD. Remodeling of chromatin structure in senescent cells and its potential impact on tumor suppression and aging. Gene 2007; 397:84 - 93; http://dx.doi.org/10.1016/j.gene.2007.04.020; PMID: 17544228
   PubMed Web of Science ®Google Scholar
• Narita M. Cellular senescence and chromatin organisation. Br J Cancer 2007; 96:686 - 91; http://dx.doi.org/10.1038/sj.bjc.6603636; PMID: 17311013
   PubMed Web of Science ®Google Scholar
• Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997; 88:593 - 602; http://dx.doi.org/10.1016/S0092-8674(00)81902-9; PMID: 9054499
   PubMed Web of Science ®Google Scholar
• Ramirez RD, Morales CP, Herbert BS, Rohde JM, Passons C, Shay JW, Wright WE. Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions. Genes Dev 2001; 15:398 - 403; http://dx.doi.org/10.1101/gad.859201; PMID: 11230148
   PubMed Web of Science ®Google Scholar
• Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, Issaeva N, Vassiliou L-VF, Kolettas E, Niforou K, Zoumpourlis VC, et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. [Internet] Nature 2006; 444:633 - 7; http://dx.doi.org/10.1038/nature05268; PMID: 17136093
   PubMed Web of Science ®Google Scholar
• Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, Luise C, Schurra C, Garre’ M, Nuciforo PG, Bensimon A, et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 2006; 444:638 - 42; http://dx.doi.org/10.1038/nature05327; PMID: 17136094
   PubMed Web of Science ®Google Scholar
• Mallette FA, Gaumont-Leclerc M-F, Ferbeyre G. The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence. Genes Dev 2007; 21:43 - 8; http://dx.doi.org/10.1101/gad.1487307; PMID: 17210786
   PubMed Web of Science ®Google Scholar
• Michaloglou C, Vredeveld LCW, Soengas MS, Denoyelle C, Kuilman T, van der Horst CMAM, Majoor DM, Shay JW, Mooi WJ, Peeper DS. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 2005; 436:720 - 4; http://dx.doi.org/10.1038/nature03890; PMID: 16079850
   PubMed Web of Science ®Google Scholar
• Collado M, Gil J, Efeyan A, Guerra C, Schuhmacher AJ, Barradas M, Benguría A, Zaballos A, Flores JM, Barbacid M, et al. Tumour biology: senescence in premalignant tumours. Nature 2005; 436:642 - 642; http://dx.doi.org/10.1038/436642a; PMID: 16079833
   PubMed Web of Science ®Google Scholar
• Chen Z, Trotman LC, Shaffer D, Lin H-K, Dotan ZA, Niki M, Koutcher JA, Scher HI, Ludwig T, Gerald W, et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 2005; 436:725 - 30; http://dx.doi.org/10.1038/nature03918; PMID: 16079851
   PubMed Web of Science ®Google Scholar
• Lazzerini Denchi E, Attwooll C, Pasini D, Helin K. Deregulated E2F activity induces hyperplasia and senescence-like features in the mouse pituitary gland. Mol Cell Biol 2005; 25:2660 - 72; http://dx.doi.org/10.1128/MCB.25.7.2660-2672.2005; PMID: 15767672
   PubMed Web of Science ®Google Scholar
• Braig M, Lee S, Loddenkemper C, Rudolph C, Peters AHFM, Schlegelberger B, Stein H, Dörken B, Jenuwein T, Schmitt CA. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 2005; 436:660 - 5; http://dx.doi.org/10.1038/nature03841; PMID: 16079837
   PubMed Web of Science ®Google Scholar
• Luger K, Dechassa ML, Tremethick DJ. New insights into nucleosome and chromatin structure: an ordered state or a disordered affair?. Nat Rev Mol Cell Biol 2012; 13:436 - 47; http://dx.doi.org/10.1038/nrm3382; PMID: 22722606
   PubMed Web of Science ®Google Scholar
• Burgess RJ, Zhang Z. Histone chaperones in nucleosome assembly and human disease. Nat Struct Mol Biol 2013; 20:14 - 22; http://dx.doi.org/10.1038/nsmb.2461; PMID: 23288364
   PubMed Web of Science ®Google Scholar
• Talbert PB, Henikoff S. Histone variants--ancient wrap artists of the epigenome. Nat Rev Mol Cell Biol 2010; 11:264 - 75; http://dx.doi.org/10.1038/nrm2861; PMID: 20197778
   PubMed Web of Science ®Google Scholar
• Szenker E, Ray-Gallet D, Almouzni G. The double face of the histone variant H3.3. Cell Res 2011; 21:421 - 34; http://dx.doi.org/10.1038/cr.2011.14; PMID: 21263457
   PubMed Web of Science ®Google Scholar
• Wu RS, Tsai S, Bonner WM. Patterns of histone variant synthesis can distinguish G0 from G1 cells. Cell 1982; 31:367 - 74; http://dx.doi.org/10.1016/0092-8674(82)90130-1; PMID: 7159927
   PubMed Web of Science ®Google Scholar
• Tagami H, Ray-Gallet D, Almouzni G, Nakatani Y. Histone H3.1 and H3.3 complexes mediate nucleosome assembly pathways dependent or independent of DNA synthesis. Cell 2004; 116:51 - 61; http://dx.doi.org/10.1016/S0092-8674(03)01064-X; PMID: 14718166
   PubMed Web of Science ®Google Scholar
• Ray-Gallet D, Woolfe A, Vassias I, Pellentz C, Lacoste N, Puri A, Schultz DC, Pchelintsev NA, Adams PD, Jansen LET, et al. Dynamics of histone H3 deposition in vivo reveal a nucleosome gap-filling mechanism for H3.3 to maintain chromatin integrity. Mol Cell 2011; 44:928 - 41; http://dx.doi.org/10.1016/j.molcel.2011.12.006; PMID: 22195966
   PubMed Web of Science ®Google Scholar
• Ahmad K, Henikoff S. The histone variant H3.3 marks active chromatin by replication-independent nucleosome assembly. Mol Cell 2002; 9:1191 - 200; http://dx.doi.org/10.1016/S1097-2765(02)00542-7; PMID: 12086617
   PubMed Web of Science ®Google Scholar
• Mito Y, Henikoff JG, Henikoff S. Genome-scale profiling of histone H3.3 replacement patterns. Nat Genet 2005; 37:1090 - 7; http://dx.doi.org/10.1038/ng1637; PMID: 16155569
   PubMed Web of Science ®Google Scholar
• Wirbelauer C, Bell O, Schübeler D. Variant histone H3.3 is deposited at sites of nucleosomal displacement throughout transcribed genes while active histone modifications show a promoter-proximal bias. Genes Dev 2005; 19:1761 - 6; http://dx.doi.org/10.1101/gad.347705; PMID: 16077006
   PubMed Web of Science ®Google Scholar
• Jin C, Zang C, Wei G, Cui K, Peng W, Zhao K, Felsenfeld G. H3.3/H2A.Z double variant-containing nucleosomes mark ‘nucleosome-free regions’ of active promoters and other regulatory regions. Nat Genet 2009; 41:941 - 5; http://dx.doi.org/10.1038/ng.409; PMID: 19633671
   PubMed Web of Science ®Google Scholar
• Chow C-M, Georgiou A, Szutorisz H, Maia e Silva A, Pombo A, Barahona I, Dargelos E, Canzonetta C, Dillon N, Dillon N. Variant histone H3.3 marks promoters of transcriptionally active genes during mammalian cell division. EMBO Rep 2005; 6:354 - 60; http://dx.doi.org/10.1038/sj.embor.7400366; PMID: 15776021
   PubMed Web of Science ®Google Scholar
• Drané P, Ouararhni K, Depaux A, Shuaib M, Hamiche A. The death-associated protein DAXX is a novel histone chaperone involved in the replication-independent deposition of H3.3. Genes Dev 2010; 24:1253 - 65; http://dx.doi.org/10.1101/gad.566910; PMID: 20504901
   PubMed Web of Science ®Google Scholar
• Goldberg AD, Banaszynski LA, Noh K-M, Lewis PW, Elsaesser SJ, Stadler S, Dewell S, Law M, Guo X, Li X, et al. Distinct factors control histone variant H3.3 localization at specific genomic regions. Cell 2010; 140:678 - 91; http://dx.doi.org/10.1016/j.cell.2010.01.003; PMID: 20211137
   PubMed Web of Science ®Google Scholar
• Wong LH, Ren H, Williams E, McGhie J, Ahn S, Sim M, Tam A, Earle E, Anderson MA, Mann J, et al. Histone H3.3 incorporation provides a unique and functionally essential telomeric chromatin in embryonic stem cells. Genome Res 2009; 19:404 - 14; http://dx.doi.org/10.1101/gr.084947.108; PMID: 19196724
   PubMed Web of Science ®Google Scholar
• Ray-Gallet D, Quivy J-P, Scamps C, Martini EM-D, Lipinski M, Almouzni G. HIRA is critical for a nucleosome assembly pathway independent of DNA synthesis. Mol Cell 2002; 9:1091 - 100; http://dx.doi.org/10.1016/S1097-2765(02)00526-9; PMID: 12049744
   PubMed Web of Science ®Google Scholar
• Balaji S, Iyer LM, Aravind L. HPC2 and ubinuclein define a novel family of histone chaperones conserved throughout eukaryotes. Mol Biosyst 2009; 5:269 - 75; http://dx.doi.org/10.1039/b816424j; PMID: 19225618
   PubMed Web of Science ®Google Scholar
• Banumathy G, Somaiah N, Zhang R, Tang Y, Hoffmann J, Andrake M, Ceulemans H, Schultz D, Marmorstein R, Adams PD. Human UBN1 is an ortholog of yeast Hpc2p and has an essential role in the HIRA/ASF1a chromatin-remodeling pathway in senescent cells. Mol Cell Biol 2009; 29:758 - 70; http://dx.doi.org/10.1128/MCB.01047-08; PMID: 19029251
   PubMed Web of Science ®Google Scholar
• Rai TS, Puri A, McBryan T, Hoffman J, Tang Y, Pchelintsev NA, van Tuyn J, Marmorstein R, Schultz DC, Adams PD. Human CABIN1 is a functional member of the human HIRA/UBN1/ASF1a histone H3.3 chaperone complex. Mol Cell Biol 2011; 31:4107 - 18; http://dx.doi.org/10.1128/MCB.05546-11; PMID: 21807893
   PubMed Web of Science ®Google Scholar
• Lewis PW, Elsaesser SJ, Noh K-M, Stadler SC, Allis CD. Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres. Proc Natl Acad Sci U S A 2010; 107:14075 - 80; http://dx.doi.org/10.1073/pnas.1008850107; PMID: 20651253
   PubMed Web of Science ®Google Scholar
• Schwartzentruber J, Korshunov A, Liu X-Y, Jones DTW, Pfaff E, Jacob K, Sturm D, Fontebasso AM, Quang D-AK, Tönjes M, et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 2012; 482:226 - 31; http://dx.doi.org/10.1038/nature10833; PMID: 22286061
   PubMed Web of Science ®Google Scholar
• Wu G, Broniscer A, McEachron TA, Lu C, Paugh BS, Becksfort J, Qu C, Ding L, Huether R, Parker M, et al, St. Jude Children’s Research Hospital–Washington University Pediatric Cancer Genome Project. Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet 2012; 44:251 - 3; http://dx.doi.org/10.1038/ng.1102; PMID: 22286216
   PubMed Web of Science ®Google Scholar
• Sturm D, Witt H, Hovestadt V, Khuong-Quang D-A, Jones DTW, Konermann C, Pfaff E, Tönjes M, Sill M, Bender S, et al. Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 2012; 22:425 - 37; http://dx.doi.org/10.1016/j.ccr.2012.08.024; PMID: 23079654
   PubMed Web of Science ®Google Scholar
• Khuong-Quang D-A, Buczkowicz P, Rakopoulos P, Liu X-Y, Fontebasso AM, Bouffet E, Bartels U, Albrecht S, Schwartzentruber J, Letourneau L, et al. K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol 2012; 124:439 - 47; http://dx.doi.org/10.1007/s00401-012-0998-0; PMID: 22661320
   PubMed Web of Science ®Google Scholar
• Jiao Y, Shi C, Edil BH, de Wilde RF, Klimstra DS, Maitra A, Schulick RD, Tang LH, Wolfgang CL, Choti MA, et al. DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science 2011; 331:1199 - 203; http://dx.doi.org/10.1126/science.1200609; PMID: 21252315
   PubMed Web of Science ®Google Scholar
• Heaphy CM, de Wilde RF, Jiao Y, Klein AP, Edil BH, Shi C, Bettegowda C, Rodriguez FJ, Eberhart CG, Hebbar S, et al. Altered telomeres in tumors with ATRX and DAXX mutations. Science 2011; 333:425; http://dx.doi.org/10.1126/science.1207313; PMID: 21719641
   PubMed Web of Science ®Google Scholar
• Papamichos-Chronakis M, Peterson CL. Chromatin and the genome integrity network. Nat Rev Genet 2013; 14:62 - 75; http://dx.doi.org/10.1038/nrg3345; PMID: 23247436
   PubMed Web of Science ®Google Scholar
• Narita M, Nũnez S, Heard E, Narita M, Lin AW, Hearn SA, Spector DL, Hannon GJ, Lowe SW. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 2003; 113:703 - 16; http://dx.doi.org/10.1016/S0092-8674(03)00401-X; PMID: 12809602
   PubMed Web of Science ®Google Scholar
• Di Micco R, Sulli G, Dobreva M, Liontos M, Botrugno OA, Gargiulo G, dal Zuffo R, Matti V, d’Ario G, Montani E, et al. Interplay between oncogene-induced DNA damage response and heterochromatin in senescence and cancer. Nat Cell Biol 2011; 13:292 - 302; http://dx.doi.org/10.1038/ncb2170; PMID: 21336312
   PubMed Web of Science ®Google Scholar
• Narita M, Narita M, Krizhanovsky V, Nuñez S, Chicas A, Hearn SA, Myers MP, Lowe SW. A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation. Cell 2006; 126:503 - 14; http://dx.doi.org/10.1016/j.cell.2006.05.052; PMID: 16901784
   PubMed Web of Science ®Google Scholar
• Zhang R, Poustovoitov MV, Ye X, Santos HA, Chen W, Daganzo SM, Erzberger JP, Serebriiskii IG, Canutescu AA, Dunbrack RL, et al. Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA. Dev Cell 2005; 8:19 - 30; http://dx.doi.org/10.1016/j.devcel.2004.10.019; PMID: 15621527
   PubMed Web of Science ®Google Scholar
• Costanzi C, Pehrson JR. Histone macroH2A1 is concentrated in the inactive X chromosome of female mammals. Nature 1998; 393:599 - 601; http://dx.doi.org/10.1038/31275; PMID: 9634239
   PubMed Web of Science ®Google Scholar
• Rai TS, Adams PD. Lessons from senescence: Chromatin maintenance in non-proliferating cells. BBA - Gene Regulatory Mechanisms 2011; 1–10.
   Google Scholar
• Ye X, Zerlanko B, Zhang R, Somaiah N, Lipinski M, Salomoni P, Adams PD. Definition of pRB- and p53-dependent and -independent steps in HIRA/ASF1a-mediated formation of senescence-associated heterochromatin foci. Mol Cell Biol 2007; 27:2452 - 65; http://dx.doi.org/10.1128/MCB.01592-06; PMID: 17242198
   PubMed Web of Science ®Google Scholar
• Bernardi R, Pandolfi PP. Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat Rev Mol Cell Biol 2007; 8:1006 - 16; http://dx.doi.org/10.1038/nrm2277; PMID: 17928811
   PubMed Web of Science ®Google Scholar
• Lallemand-Breitenbach V, de Thé H. PML nuclear bodies. Cold Spring Harb Perspect Biol 2010; 2:a000661 - 000661; http://dx.doi.org/10.1101/cshperspect.a000661; PMID: 20452955
   PubMed Web of Science ®Google Scholar
• Pearson M, Carbone R, Sebastiani C, Cioce M, Fagioli M, Saito S, Higashimoto Y, Appella E, Minucci S, Pandolfi PP, et al. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature 2000; 406:207 - 10; http://dx.doi.org/10.1038/35021000; PMID: 10910364
   PubMed Web of Science ®Google Scholar
• Ferbeyre G, de Stanchina E, Querido E, Baptiste N, Prives C, Lowe SW. PML is induced by oncogenic ras and promotes premature senescence. Genes Dev 2000; 14:2015 - 27; PMID: 10950866
   PubMed Web of Science ®Google Scholar
• Jansen LET, Black BE, Foltz DR, Cleveland DW. Propagation of centromeric chromatin requires exit from mitosis. J Cell Biol 2007; 176:795 - 805; http://dx.doi.org/10.1083/jcb.200701066; PMID: 17339380
   PubMed Web of Science ®Google Scholar
• Keppler A, Gendreizig S, Gronemeyer T, Pick H, Vogel H, Johnsson K. A general method for the covalent labeling of fusion proteins with small molecules in vivo. Nat Biotechnol 2003; 21:86 - 9; http://dx.doi.org/10.1038/nbt765; PMID: 12469133
   PubMed Web of Science ®Google Scholar
• Bodor DL, Rodríguez MG, Moreno N, Jansen LET. Analysis of protein turnover by quantitative SNAP-based pulse-chase imaging. Curr Protoc Cell Biol 2012; Chapter 8:Unit8.8.
   Google Scholar
• Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 1995; 92:9363 - 7; http://dx.doi.org/10.1073/pnas.92.20.9363; PMID: 7568133
   PubMed Web of Science ®Google Scholar
• Debacq-Chainiaux F, Erusalimsky JD, Campisi J, Toussaint O. Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nat Protoc 2009; 4:1798 - 806; http://dx.doi.org/10.1038/nprot.2009.191; PMID: 20010931
   PubMed Web of Science ®Google Scholar
• Young ARJ, Narita M, Ferreira M, Kirschner K, Sadaie M, Darot JFJ, Tavaré S, Arakawa S, Shimizu S, Watt FM, et al. Autophagy mediates the mitotic senescence transition. Genes Dev 2009; 23:798 - 803; http://dx.doi.org/10.1101/gad.519709; PMID: 19279323
   PubMed Web of Science ®Google Scholar
• Corpet A, De Koning L, Toedling J, Savignoni A, Berger F, Lemaître C, O’Sullivan RJ, Karlseder J, Barillot E, Asselain B, et al. Asf1b, the necessary Asf1 isoform for proliferation, is predictive of outcome in breast cancer. EMBO J 2011; 30:480 - 93; http://dx.doi.org/10.1038/emboj.2010.335; PMID: 21179005
   PubMed Web of Science ®Google Scholar
• Xue Y, Gibbons R, Yan Z, Yang D, McDowell TL, Sechi S, Qin J, Zhou S, Higgs D, Wang W. The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies. Proc Natl Acad Sci U S A 2003; 100:10635 - 40; http://dx.doi.org/10.1073/pnas.1937626100; PMID: 12953102
   PubMed Web of Science ®Google Scholar
• Ishov AM, Vladimirova OV, Maul GG. Heterochromatin and ND10 are cell-cycle regulated and phosphorylation-dependent alternate nuclear sites of the transcription repressor Daxx and SWI/SNF protein ATRX. J Cell Sci 2004; 117:3807 - 20; http://dx.doi.org/10.1242/jcs.01230; PMID: 15252119
   PubMed Web of Science ®Google Scholar
• Jiang W-Q, Nguyen A, Cao Y, Chang AC-M, Reddel RR. HP1-mediated formation of alternative lengthening of telomeres-associated PML bodies requires HIRA but not ASF1a. PLoS One 2011; 6:e17036; http://dx.doi.org/10.1371/journal.pone.0017036; PMID: 21347226
   PubMed Web of Science ®Google Scholar
• Wang J, Shiels C, Sasieni P, Wu PJ, Islam SA, Freemont PS, Sheer D. Promyelocytic leukemia nuclear bodies associate with transcriptionally active genomic regions. J Cell Biol 2004; 164:515 - 26; http://dx.doi.org/10.1083/jcb.200305142; PMID: 14970191
   PubMed Web of Science ®Google Scholar
• Kiesslich A, von Mikecz A, Hemmerich P. Cell cycle-dependent association of PML bodies with sites of active transcription in nuclei of mammalian cells. J Struct Biol 2002; 140:167 - 79; http://dx.doi.org/10.1016/S1047-8477(02)00571-3; PMID: 12490165
   PubMed Web of Science ®Google Scholar
• Boisvert F-M, Hendzel MJ, Bazett-Jones DP. Promyelocytic leukemia (PML) nuclear bodies are protein structures that do not accumulate RNA. J Cell Biol 2000; 148:283 - 92; http://dx.doi.org/10.1083/jcb.148.2.283; PMID: 10648561
   PubMed Web of Science ®Google Scholar
• Maison C, Almouzni G. HP1 and the dynamics of heterochromatin maintenance. Nat Rev Mol Cell Biol 2004; 5:296 - 304; http://dx.doi.org/10.1038/nrm1355; PMID: 15071554
   PubMed Web of Science ®Google Scholar
• Morozov VM, Gavrilova EV, Ogryzko VV, Ishov AM. Dualistic function of Daxx at centromeric and pericentromeric heterochromatin in normal and stress conditions. Nucleus 2012; 3:276 - 85; http://dx.doi.org/10.4161/nucl.20180; PMID: 22572957
   PubMed Web of Science ®Google Scholar
• Deal RB, Henikoff JG, Henikoff S. Genome-wide kinetics of nucleosome turnover determined by metabolic labeling of histones. Science 2010; 328:1161 - 4; http://dx.doi.org/10.1126/science.1186777; PMID: 20508129
   PubMed Web of Science ®Google Scholar
• De Cecco M, Jeyapalan J, Zhao X, Tamamori-Adachi M, Sedivy JM. Nuclear protein accumulation in cellular senescence and organismal aging revealed with a novel single-cell resolution fluorescence microscopy assay. Aging (Albany NY) 2011; 3:955 - 67; PMID: 22006542
   PubMedGoogle Scholar
• Lopez MF, Tollervey J, Krastins B, Garces A, Sarracino D, Prakash A, Vogelsang M, Geesman G, Valderrama A, Jordan IK, et al. Depletion of nuclear histone H2A variants is associated with chronic DNA damage signaling upon drug-evoked senescence of human somatic cells. Aging (Albany NY) 2012; 4:823 - 42; PMID: 23235539
   PubMedGoogle Scholar
• O’Sullivan RJ, Kubicek S, Schreiber SL, Karlseder J. Reduced histone biosynthesis and chromatin changes arising from a damage signal at telomeres. Nat Struct Mol Biol 2010; 17:1218 - 25; http://dx.doi.org/10.1038/nsmb.1897; PMID: 20890289
   PubMed Web of Science ®Google Scholar
• Polo SE, Theocharis SE, Klijanienko J, Savignoni A, Asselain B, Vielh P, Almouzni G. Chromatin assembly factor-1, a marker of clinical value to distinguish quiescent from proliferating cells. Cancer Res 2004; 64:2371 - 81; http://dx.doi.org/10.1158/0008-5472.CAN-03-2893; PMID: 15059888
   PubMed Web of Science ®Google Scholar
• Ng RK, Gurdon JB. Epigenetic memory of an active gene state depends on histone H3.3 incorporation into chromatin in the absence of transcription. Nat Cell Biol 2008; 10:102 - 9; http://dx.doi.org/10.1038/ncb1674; PMID: 18066050
   PubMed Web of Science ®Google Scholar
• Beauséjour CM, Krtolica A, Galimi F, Narita M, Lowe SW, Yaswen P, Campisi J. Reversal of human cellular senescence: roles of the p53 and p16 pathways. [Internet] EMBO J 2003; 22:4212 - 22; http://dx.doi.org/10.1093/emboj/cdg417; PMID: 12912919
   PubMed Web of Science ®Google Scholar
• Chandra T, Narita M. High-order chromatin structure and the epigenome in SAHFs. Nucleus 2013; 4:23 - 8; http://dx.doi.org/10.4161/nucl.23189; PMID: 23232545
   PubMed Web of Science ®Google Scholar
• Hake SB, Garcia BA, Duncan EM, Kauer M, Dellaire G, Shabanowitz J, Bazett-Jones DP, Allis CD, Hunt DF. Expression patterns and post-translational modifications associated with mammalian histone H3 variants. J Biol Chem 2006; 281:559 - 68; http://dx.doi.org/10.1074/jbc.M509266200; PMID: 16267050
   PubMed Web of Science ®Google Scholar
• McKittrick E, Gafken PR, Ahmad K, Henikoff S. Histone H3.3 is enriched in covalent modifications associated with active chromatin. Proc Natl Acad Sci U S A 2004; 101:1525 - 30; http://dx.doi.org/10.1073/pnas.0308092100; PMID: 14732680
   PubMed Web of Science ®Google Scholar
• Chandra T, Kirschner K, Thuret J-Y, Pope BD, Ryba T, Newman S, Ahmed K, Samarajiwa SA, Salama R, Carroll T, et al. Independence of repressive histone marks and chromatin compaction during senescent heterochromatic layer formation. Mol Cell 2012; 47:203 - 14; http://dx.doi.org/10.1016/j.molcel.2012.06.010; PMID: 22795131
   PubMed Web of Science ®Google Scholar
• Zhang R, Chen W, Adams PD. Molecular dissection of formation of senescence-associated heterochromatin foci. Mol Cell Biol 2007; 27:2343 - 58; http://dx.doi.org/10.1128/MCB.02019-06; PMID: 17242207
   PubMed Web of Science ®Google Scholar
• Kosar M, Bartkova J, Hubackova S, Hodny Z, Lukas J, Bartek J. Senescence-associated heterochromatin foci are dispensable for cellular senescence, occur in a cell type- and insult-dependent manner and follow expression of p16(ink4a). Cell Cycle 2011; 10:457 - 68; http://dx.doi.org/10.4161/cc.10.3.14707; PMID: 21248468
   PubMed Web of Science ®Google Scholar
• Loyola A, Bonaldi T, Roche D, Imhof A, Almouzni G. PTMs on H3 variants before chromatin assembly potentiate their final epigenetic state. Mol Cell 2006; 24:309 - 16; http://dx.doi.org/10.1016/j.molcel.2006.08.019; PMID: 17052464
   PubMed Web of Science ®Google Scholar
• de Stanchina E, Querido E, Narita M, Davuluri RV, Pandolfi PP, Ferbeyre G, Lowe SW. PML is a direct p53 target that modulates p53 effector functions. Mol Cell 2004; 13:523 - 35; http://dx.doi.org/10.1016/S1097-2765(04)00062-0; PMID: 14992722
   PubMed Web of Science ®Google Scholar
• Elsässer SJ, Huang H, Lewis PW, Chin JW, Allis CD, Patel DJ. DAXX envelops a histone H3.3-H4 dimer for H3.3-specific recognition. Nature 2012; 491:560 - 5; http://dx.doi.org/10.1038/nature11608; PMID: 23075851
   PubMed Web of Science ®Google Scholar
• Liu C-P, Xiong C, Wang M, Yu Z, Yang N, Chen P, Zhang Z, Li G, Xu R-M. Structure of the variant histone H3.3-H4 heterodimer in complex with its chaperone DAXX. Nat Struct Mol Biol 2012; 19:1287 - 92; http://dx.doi.org/10.1038/nsmb.2439; PMID: 23142979
   PubMed Web of Science ®Google Scholar
• Delbarre E, Ivanauskiene K, Küntziger T, Collas P. DAXX-dependent supply of soluble (H3.3-H4) dimers to PML bodies pending deposition into chromatin. Genome Res 2013; 23:440 - 51; http://dx.doi.org/10.1101/gr.142703.112; PMID: 23222847
   PubMed Web of Science ®Google Scholar
• Dhayalan A, Tamas R, Bock I, Tattermusch A, Dimitrova E, Kudithipudi S, Ragozin S, Jeltsch A. The ATRX-ADD domain binds to H3 tail peptides and reads the combined methylation state of K4 and K9. Hum Mol Genet 2011; 20:2195 - 203; http://dx.doi.org/10.1093/hmg/ddr107; PMID: 21421568
   PubMed Web of Science ®Google Scholar
• Lechner MS, Schultz DC, Negorev D, Maul GG, Rauscher FJ 3rd. The mammalian heterochromatin protein 1 binds diverse nuclear proteins through a common motif that targets the chromoshadow domain. Biochem Biophys Res Commun 2005; 331:929 - 37; http://dx.doi.org/10.1016/j.bbrc.2005.04.016; PMID: 15882967
   PubMed Web of Science ®Google Scholar
• Ratnakumar K, Duarte LF, LeRoy G, Hasson D, Smeets D, Vardabasso C, Bönisch C, Zeng T, Xiang B, Zhang DY, et al. ATRX-mediated chromatin association of histone variant macroH2A1 regulates α-globin expression. Genes Dev 2012; 26:433 - 8; http://dx.doi.org/10.1101/gad.179416.111; PMID: 22391447
   PubMed Web of Science ®Google Scholar
• Dellaire G, Bazett-Jones DP. PML nuclear bodies: dynamic sensors of DNA damage and cellular stress. Bioessays 2004; 26:963 - 77; http://dx.doi.org/10.1002/bies.20089; PMID: 15351967
   PubMed Web of Science ®Google Scholar
• Luciani JJ, Depetris D, Usson Y, Metzler-Guillemain C, Mignon-Ravix C, Mitchell MJ, Megarbane A, Sarda P, Sirma H, Moncla A, et al. PML nuclear bodies are highly organised DNA-protein structures with a function in heterochromatin remodelling at the G2 phase. J Cell Sci 2006; 119:2518 - 31; http://dx.doi.org/10.1242/jcs.02965; PMID: 16735446
   PubMed Web of Science ®Google Scholar
• Seeler JS, Marchio A, Sitterlin D, Transy C, Dejean A. Interaction of SP100 with HP1 proteins: a link between the promyelocytic leukemia-associated nuclear bodies and the chromatin compartment. Proc Natl Acad Sci U S A 1998; 95:7316 - 21; http://dx.doi.org/10.1073/pnas.95.13.7316; PMID: 9636146
   PubMed Web of Science ®Google Scholar
• Kepkay R, Attwood KM, Ziv Y, Shiloh Y, Dellaire G. KAP1 depletion increases PML nuclear body number in concert with ultrastructural changes in chromatin. Cell Cycle 2011; 10:308 - 22; http://dx.doi.org/10.4161/cc.10.2.14551; PMID: 21228624
   PubMed Web of Science ®Google Scholar
• Chang FTM, McGhie JD, Chan FL, Tang MC, Anderson MA, Mann JR, Andy Choo KH, Wong LH. PML bodies provide an important platform for the maintenance of telomeric chromatin integrity in embryonic stem cells. Nucleic Acids Res 2013; 41:4447 - 58; http://dx.doi.org/10.1093/nar/gkt114; PMID: 23444137
   PubMed Web of Science ®Google Scholar
• Vernier M, Bourdeau V, Gaumont-Leclerc M-F, Moiseeva O, Bégin V, Saad F, Mes-Masson A-M, Ferbeyre G. Regulation of E2Fs and senescence by PML nuclear bodies. Genes Dev 2011; 25:41 - 50; http://dx.doi.org/10.1101/gad.1975111; PMID: 21205865
   PubMed Web of Science ®Google Scholar
• Pear W. Transient transfection methods for preparation of high-titer retroviral supernatants. Curr Protoc Mol Biol 2001; Chapter 9:Unit9.11.
   Google Scholar
• Cantrell SR, Bresnahan WA. Human cytomegalovirus (HCMV) UL82 gene product (pp71) relieves hDaxx-mediated repression of HCMV replication. J Virol 2006; 80:6188 - 91; http://dx.doi.org/10.1128/JVI.02676-05; PMID: 16731959
   PubMed Web of Science ®Google Scholar
• Ritchie K, Seah C, Moulin J, Isaac C, Dick F, Bérubé NG. Loss of ATRX leads to chromosome cohesion and congression defects. J Cell Biol 2008; 180:315 - 24; http://dx.doi.org/10.1083/jcb.200706083; PMID: 18227278
   PubMed Web of Science ®Google Scholar
• Naviaux RK, Costanzi E, Haas M, Verma IM. The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses. J Virol 1996; 70:5701 - 5; PMID: 8764092
   PubMed Web of Science ®Google Scholar
• Sambrook J, Russell DW. Calcium-phosphate-mediated Transfection of Eukaryotic Cells with Plasmid DNAs. CSH Protoc 2006; 2006
   Google Scholar
• Chen LY, Chen JD. Daxx silencing sensitizes cells to multiple apoptotic pathways. Mol Cell Biol 2003; 23:7108 - 21; http://dx.doi.org/10.1128/MCB.23.20.7108-7121.2003; PMID: 14517282
   PubMed Web of Science ®Google Scholar
• Zhang X, Gu L, Li J, Shah N, He J, Yang L, Hu Q, Zhou M. Degradation of MDM2 by the interaction between berberine and DAXX leads to potent apoptosis in MDM2-overexpressing cancer cells. Cancer Res 2010; 70:9895 - 904; http://dx.doi.org/10.1158/0008-5472.CAN-10-1546; PMID: 20935220
   PubMed Web of Science ®Google Scholar
• Zhang R, Liu S-T, Chen W, Bonner M, Pehrson J, Yen TJ, Adams PD. HP1 proteins are essential for a dynamic nuclear response that rescues the function of perturbed heterochromatin in primary human cells. Mol Cell Biol 2007; 27:949 - 62; http://dx.doi.org/10.1128/MCB.01639-06; PMID: 17101789
   PubMed Web of Science ®Google Scholar
• Perfettini J-L, Nardacci R, Séror C, Bourouba M, Subra F, Gros L, Manic G, Amendola A, Masdehors P, Rosselli F, et al. The tumor suppressor protein PML controls apoptosis induced by the HIV-1 envelope. Cell Death Differ 2009; 16:298 - 311; http://dx.doi.org/10.1038/cdd.2008.158; PMID: 19023333
   PubMed Web of Science ®Google Scholar
• Martini E, Roche DM, Marheineke K, Verreault A, Almouzni G. Recruitment of phosphorylated chromatin assembly factor 1 to chromatin after UV irradiation of human cells. J Cell Biol 1998; 143:563 - 75; http://dx.doi.org/10.1083/jcb.143.3.563; PMID: 9813080
   PubMed Web of Science ®Google Scholar
• O’Geen H, Echipare L, Farnham PJ. Using ChIP-Seq Technology to Generate High-Resolution Profiles of Histone Modifications. In: Methods in Molecular Biology. Totowa, NJ: Humana Press; 2011.:265–286.
   Google Scholar